The report features PAGB’s activity relating to MHRA performance, EU Exit, the provision of advertising and regulatory advice and training for members and includes how PAGB secured positive outcomes for the industry in discussions with Government ministers and officials – on batch testing, the Northern Ireland Protocol, medical device regulation and more.
It also outlines our increased media and advocacy work and our efforts to promote self-care and reclassification and analysis from NielsenIQ on changing market conditions, challenges and opportunities in the last year.
